🎁 Black Friday: up to 50% off of annual plans
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.200
-0.140 (-5.98%)
At close: Nov 20, 2026, 4:00 PM EST
2.298
+0.098 (4.47%)
After-hours: Nov 20, 2026, 7:59 PM EST

Ovid Therapeutics Statistics

Total Valuation

OVID has a market cap or net worth of $415.21 million. The enterprise value is $266.14 million.

Market Cap415.21M
Enterprise Value 266.14M

Important Dates

The last earnings date was Tuesday, November 10, 2026, before market open.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

OVID has 188.73 million shares outstanding. The number of shares has increased by 117.58% in one year.

Current Share Class 188.73M
Shares Outstanding 188.73M
Shares Change (YoY) +117.58%
Shares Change (QoQ) +2.82%
Owned by Insiders (%) 2.26%
Owned by Institutions (%) 79.37%
Float 167.32M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 285.76
Forward PS 3,139.11
PB Ratio 2.09
P/TBV Ratio 2.09
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 183.17
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.97, with a Debt / Equity ratio of 0.06.

Current Ratio 11.97
Quick Ratio 11.52
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -35.43% and return on invested capital (ROIC) is -127.14%.

Return on Equity (ROE) -35.43%
Return on Assets (ROA) -29.95%
Return on Invested Capital (ROIC) -127.14%
Return on Capital Employed (ROCE) -32.42%
Weighted Average Cost of Capital (WACC) 5.42%
Revenue Per Employee $63,174
Profits Per Employee -$1.86M
Employee Count23
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +71.88% in the last 52 weeks. The beta is 0.24, so OVID's price volatility has been lower than the market average.

Beta (5Y) 0.24
52-Week Price Change +71.88%
50-Day Moving Average 2.46
200-Day Moving Average 2.43
Relative Strength Index (RSI) 40.73
Average Volume (20 Days) 2,559,295

Short Selling Information

The latest short interest is 18.13 million, so 9.61% of the outstanding shares have been sold short.

Short Interest 18.13M
Short Previous Month 18.07M
Short % of Shares Out 9.61%
Short % of Float 10.84%
Short Ratio (days to cover) 9.91

Income Statement

In the last 12 months, OVID had revenue of $1.45 million and -$42.84 million in losses. Loss per share was -$0.28.

Revenue1.45M
Gross Profit 1.45M
Operating Income -68.20M
Pretax Income -43.11M
Net Income -42.84M
EBITDA -68.12M
EBIT -68.20M
Loss Per Share -$0.28
Full Income Statement

Balance Sheet

The company has $161.42 million in cash and investments and $12.35 million in debt, with a net cash position of $149.07 million or $0.79 per share.

Cash & Investments 161.42M
Total Debt 12.35M
Net Cash 149.07M
Net Cash Per Share $0.79
Equity (Book Value) 198.67M
Book Value Per Share 1.05
Working Capital 130.10M
Full Balance Sheet

Cash Flow

Operating Cash Flow -57.78M
Capital Expenditures n/a
Depreciation & Amortization 83,000
Net Borrowing n/a
Free Cash Flow -57.78M
FCF Per Share -$0.31
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -4,693.74%
Pretax Margin -2,967.24%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

OVID does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -117.58%
Shareholder Yield -117.58%
Earnings Yield -12.59%
FCF Yield -13.92%

Analyst Forecast

The average price target for OVID is $6.15, which is 179.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.15
Price Target Difference 179.55%
Analyst Consensus Strong Buy
Analyst Count 13
Revenue Growth Forecast (3Y) -67.29%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

OVID has an Altman Z-Score of 5.64 and a Piotroski F-Score of 1.

Altman Z-Score 5.64
Piotroski F-Score 1